Centrum Htasp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2011-03-08
Share capital
10 000,00 PLN
Activity description

Centrum Hta provides consulting services for the Polish pharmaceutical market, including health technology assessment analyses for medicines and medical devices. Its services include full HTA reports, clinical and cost analyses, budget impact analyses for reimbursement decisions, reimbursement documentation, training, and rapid reviews.

Registered address
os. Mozarta 1/29, 31-232 Kraków, Poland
Website
centrumhta.comWebsite active
Email
Email address current
Phone
Social media
Electronic delivery address
AE:PL-61279-16331-RBGID-21

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 479.26kMedianUSD 72.17kAverageUSD 3.11m
Net profit
This companyUSD 199.00kMedianUSD 69.14AverageUSD 80.67k
Operating costs
This companyUSD 259.40kMedianUSD 75.48kAverageUSD 2.93m
Assets
This companyUSD 154.26kMedianUSD 121.09kAverageUSD 3.89m

Bank accounts

Registered as a VAT taxpayer on 2015-09-23. Active

  • mBank
    75 1140 2004 0000 3002 8196 2881
  • mBank
    86 1140 2004 0000 3012 2363 8683

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Authorized Representatives

Paweł Piotr Kawalec – President

Manner of representation

The one-person management board represents the company independently in all matters. If a multi-member management board is appointed, the following are authorised to make declarations on behalf of the company: the President of the Management Board acting independently, or two members of the management board acting jointly.

Ownership

OwnerSharesShare valueStake
Katarzyna Magdalena Kawalec
50$675.3125%
Paweł Piotr Kawalec (51)
150$2,025.9375%

Paweł Piotr Kawalec and Katarzyna Magdalena Kawalec hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Competitors

Name
Aurevia Polandsp. z o.o.
Analytical R & Dsp. z o.o.
Centrum Funduszy Uesp. z o.o.
CTI Clinical Trial and Consulting Services Polandsp. z o.o.
Proper Medical Writingsp. z o.o.
Inovintellsp. z o.o.
HTA Formedissp. z o.o.
CCTSsp. z o.o.
Specjalistyczne Gabinetysp. z o.o.
TCIsp. z o.o.

Change history

DateEvent
2022-02-17PKD change
2011-03-08Entered in the register

FAQ

Last updated: 2026-04-20